Autor: |
Bessa A; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK. Electronic address: Agustina.bessa@kcl.ac.uk., Maclennan S; Academic Urology Unit, University of Aberdeen, Aberdeen, UK., Enting D; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK; Guy's and St Thomas' NHS Foundation Trust, Dept of Medical Oncology, London, UK., Bryan R; Institute of Cancer & Genomic Sciences, University of Birmingham, UK., Josephs D; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK; Guy's and St Thomas' NHS Foundation Trust, Dept of Medical Oncology, London, UK., Hughes S; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK; Department of Clinical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Amery S; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Khan MS; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Malde S; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Nair R; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Cahill F; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK., Wylie H; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK., Thurairaja R; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Chatterton K; Department of Urology, Guy's and St Thomas' NHS Foundation Trust, London, UK., Kinsella N; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK; Royal Marsden NHS Foundation Trust, London, UK., Häggström C; Department of Surgical Sciences, Uppsala University, Uppsala, Sweden; Department of Biobank Research, Umeå University, Umeå, Sweden., Van Hemelrijck M; School of Cancer and Pharmaceutical Studies, Translational Oncology & Urology Research (TOUR), King's College London, London, UK. |